Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
The Dixie Group | DXYN | Sep 27, 2024 | 0.70 | +0.64 |
The Duckhorn Portfolio | NAPA | Sep 27, 2024 | 5.89 | +1.55 |
The Ensign Group | ENSG | Sep 27, 2024 | 144.11 | -2.25 |
The European Equity Fund | EEA | Sep 27, 2024 | 9.45 | -0.16 |
The First Bancshares | FBMS | Sep 27, 2024 | 31.65 | +0.16 |
The Gabelli Healthcare & Wellness Trust | GRX | Sep 27, 2024 | 10.99 | -0.27 |
The Gdl Fund | GDL | Sep 27, 2024 | 8.20 | +0.86 |
The Glimpse Group | VRAR | Sep 27, 2024 | 0.80 | -6.29 |
The Hackett Group | HCKT | Sep 27, 2024 | 25.97 | -0.38 |
The Hain Celestial Group | HAIN | Sep 27, 2024 | 8.57 | +3.75 |
The Hershey | HSY | Sep 27, 2024 | 193.36 | +1.49 |
The Herzfeld Caribbean Basin Fund | CUBA | Sep 27, 2024 | 2.30 | -1.29 |
The Honest Company | HNST | Sep 27, 2024 | 3.64 | 0.00 |
The Intergroup | INTG | Sep 27, 2024 | 15.26 | +4.02 |
The J.M Smucker Company | SJM | Sep 27, 2024 | 121.15 | +1.07 |
The Joint | JYNT | Sep 27, 2024 | 11.59 | +0.35 |
The Marygold Companies | MGLD | Sep 27, 2024 | 1.45 | +0.35 |
The ODP | ODP | Sep 27, 2024 | 29.37 | +2.16 |
The OLB Group | OLB | Sep 27, 2024 | 2.91 | -2.01 |
The Oncology Institute | TOI | Sep 27, 2024 | 0.31 | +3.41 |
The ONE Group Hospitality | STKS | Sep 27, 2024 | 3.75 | +1.90 |
The Pennant Group | PNTG | Sep 27, 2024 | 34.39 | -0.84 |
The Real Brokerage | REAX | Sep 27, 2024 | 5.53 | -1.60 |
The Real Estate Select Sector SPDR Fund | XLRE | Sep 27, 2024 | 44.29 | +0.14 |
The RealReal | REAL | Sep 27, 2024 | 3.25 | +4.17 |
The RMR Group A | RMR | Sep 27, 2024 | 24.89 | +0.40 |
The Shyft Group | SHYF | Sep 27, 2024 | 12.60 | +1.69 |
The Trade Desk A | TTD | Sep 27, 2024 | 109.45 | +0.08 |
The9 ADR | NCTY | Sep 27, 2024 | 6.85 | -1.32 |
TherapeuticsMD | TXMD | Sep 27, 2024 | 1.64 | -0.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.